These findings showed that BAL may suppress hepatic DNL through regulating the activities of SREBP1c and ChREBP, which are the important regulatory mechanisms of BAL for relieving fructose-induced hepatic steatosis. This evidence concerns the gene MLXIPL and fatty liver disease.